Literature DB >> 1100784

Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophypopseal system.

D F Swaab, C W Pool, F Nijveldt.   

Abstract

The present paper deals with the development of an immunofluorescence procedure that allows specific localization of vasopressin and oxytocin in the hypothalamo-neurohypophyseal system(hnx) of the rat. Antibodies against arginine vasopressin (AVP), lysine-vasopressin (LVP) and oxytocin were raised by injecting these hormones that were covalently bound to thyroglobulin into rabbits. The vasopressin-immunized rabbits showed periods of diabetes insipidus, while histoloty of the "hns revealed an intact neurosecretory system with signs of increased endogenous hormone synthesis in the supraoptic nucleus and increased release in the neuro-hypophysis of some rabbits. The daily water intake of the oxytocin-immunized rabbits was similar to that of control rabbits. The development of antibodies against vasopressin as measured in the immunofluorescence procedure showed a course that was quite different from the curve of the titer as determined by radioimmunoassay (RIA). Also the specificity of the antibodies used in the immunofluorescence procedure was found to be quite different from their specificity in a RIA system. Potency and specificity of the antibodies have to be studied therefore within the immunofluorescence procedure itself. Using freshly frozen acetone-postfixed hypotalami or pituitaries, no sharp localization of immunofluorescence could be obtained in the HNS. Therefore prefixation was performed. Both, the type and the duration of prefixation revealed quite different results regarding the immunofluorescence in the neurosecretory cell boides in the hypotalamus and of their endings in the neurohypophysis. The best immunofluorescence results were obtained using 6 hours glyoxal-prefixation for the hypothalamus and 24 hours formalin-prefixation for the pituitary. The cross-reaction of the antibodies for oxytocin or vasopressin was tested on synthetic hormones that were bound to CNBR-activated agarose beads and mounted on glass sides. All anti-plasmas showed cross-reaction on beads containing the heterologou- antigen. The plasmas were purified by incubation with beads containing the heterologous hormone until the cross-reacting component had been removed. Using purified antibodies, the distribution of oxytocin and vasopressin cells within the HNS was investigated. More oxytocin containing cells were localized in the rostral part and more vasopressin in the caudal part of both, the supraoptic (SON) and paraventricular nucleus (PVN). Comparable percentages of oxytocin and vasopressin containing cells were found in the SON and PVN. The absolute amount of oxytocin containing cells was 2.5 times more in the SON than in the PVN, which seems to contradict the "classical" view that the PVN predominantly or entirely synthetizes oxytocin. In addition, fluorescence was found using antobodies against vasopressin in the suprachiasmatic nucleus in Wistar rats and heterozygous Brattleboro rats, but not in this nucleus of homozygous Brattleboros.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100784     DOI: 10.1007/bf01253126

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  23 in total

1.  Estimation of nuclear population from microtome sections.

Authors:  M ABERCROMBIE
Journal:  Anat Rec       Date:  1946-02

2.  A radioimmunoassay of vasopressin. A note on pituitary vasopressin content in Brattleboro rats.

Authors:  T B van Wimersma Greidanus; R M Buys; H J Hollemans; W de Jong
Journal:  Experientia       Date:  1974-10-15

3.  Synthesis of both neurohypophysial hormones in both the paraventricular and supraoptic nuclei of the rat.

Authors:  G D Burford; R E Dyball; R L Moss; B T Pickering
Journal:  J Anat       Date:  1974-04       Impact factor: 2.610

4.  The effect of hypothalamic deafferentation upon the ultrastructure and hormone content of the paraventricular nucleus.

Authors:  R G Dyer; R E Dyball; J F Morris
Journal:  J Endocrinol       Date:  1973-06       Impact factor: 4.286

5.  The use of thyroglobulin to induce antigenicity to small molecules.

Authors:  W R Skowsky; D A Fisher
Journal:  J Lab Clin Med       Date:  1972-07

6.  Storage and secretion of neurohypophyseal hormones.

Authors:  F S LaBella
Journal:  Can J Physiol Pharmacol       Date:  1968-03       Impact factor: 2.273

7.  The hypothalamic neurosecretory activity during the oestrous cycle, pregnancy, parturition, lactation, and persistent oestrus, and after gonadectomy, in the rat.

Authors:  D F Swaab; J F Jongkind
Journal:  Neuroendocrinology       Date:  1970       Impact factor: 4.914

8.  In vivo and in vitro inactivation of biological activity of vasopressin by antiserum to lysine vasopressin.

Authors:  M Miller; A M Moses
Journal:  Endocrinology       Date:  1969-04       Impact factor: 4.736

9.  Histochemical studies on the morphology of the Golgi apparatus and on the distribution of hexokinase, phosphoglucomutase and some dehydrogenases in the dorsal vagal and hypoglossal nuclei of the rabbit.

Authors:  K Iijima
Journal:  Histochemie       Date:  1969

10.  Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation.

Authors:  D D SABATINI; K BENSCH; R J BARRNETT
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  50 in total

1.  Identification, in the external region of the rat median eminence, of separate neurophysin-vasopressin and neurophysin-oxytocin containing nerve fibres.

Authors:  K Dierickx; F Vandesande; J de Mey
Journal:  Cell Tissue Res       Date:  1976-05-06       Impact factor: 5.249

2.  Lactation-associated redistribution of the glial fibrillary acidic protein within the supraoptic nucleus. An immunocytochemical study.

Authors:  A K Salm; K G Smithson; G I Hatton
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

Review 3.  The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings.

Authors:  David M Cochran; Daniel Fallon; Michael Hill; Jean A Frazier
Journal:  Harv Rev Psychiatry       Date:  2013 Sep-Oct       Impact factor: 3.732

4.  Cytochemical duality of neurosecretory material in the hypothalamo-posthypophysial system of the rat as related to hormonal content.

Authors:  F Tasso; S Rua; D Picard
Journal:  Cell Tissue Res       Date:  1977-05-10       Impact factor: 5.249

5.  Electron microscopic immunocytochemical demonstration of separate neurophysin-vasopressinergic and neurophysin-oxytocinergic nerve fibres in the neural lobe of the rat hypophysis.

Authors:  M R Aspeslagh; F Vandesande; K Dierickx
Journal:  Cell Tissue Res       Date:  1976-08-16       Impact factor: 5.249

6.  Specific immunoelectronmicroscopic localization of vasopressin and oxytocin in the neurohypophysis of the rat.

Authors:  F W van Leeuwen; D F Swaab
Journal:  Cell Tissue Res       Date:  1977-02-14       Impact factor: 5.249

7.  Immunocytochemical study of the hypothalamo-neurohypophysial system. II. Distribution of neurophysin, vasopressin and oxytocin in the normal and osmotically stimulated rat.

Authors:  V J Choy; W B Watkins
Journal:  Cell Tissue Res       Date:  1977-06-13       Impact factor: 5.249

8.  Neuropeptide proctolin (H-Arg-Tyr-Leu-Pro-Thr-OH): immunological detection and neuronal localization in insect central nervous system.

Authors:  C A Bishop; M O'Shea; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

9.  Localisation of oxytocin, vasopressin and parts of precursors in the human neonatal adrenal.

Authors:  R Ravid; H P Oosterbaan; B L Hansen; D F Swaab
Journal:  Histochemistry       Date:  1986

10.  Vasopressin receptor V1a regulates circadian rhythms of locomotor activity and expression of clock-controlled genes in the suprachiasmatic nuclei.

Authors:  Jia-Da Li; Katherine J Burton; Chengkang Zhang; Shuang-Bao Hu; Qun-Yong Zhou
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-03       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.